SCHEMBL4166182

SCHEMBL4166182

O=C(N[C@@H](CCCSCC(=O)C(F)(F)F)C(=O)NCc1csc(-c2ccccc2)n1)c1ccc2nccnc2c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PADI4 Q9UM07 3/20 0.48
PADI2 Q9Y2J8 3/20 0.48
ROCK2 O75116 2/20 0.39
GRK2 P25098 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KDM1A O60341 4/20 0.38
MCHR1 Q99705 2/20 0.37
HPGD P15428 1/20 0.37
ROCK1 Q13464 1/20 0.37
RHOC P08134 1/20 0.36
RHOA P61586 1/20 0.36
MAOA P21397 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
NAMPT P43490 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 2/20 0.35
SHMT1 P34896 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4159878 0.84 ROCK2 (0.45) ROCK2GRK2NPC1RAB9AHPGD
SCHEMBL4149913 0.84 SMN1; SMN2 (0.43) ROCK2GRK2NPC1RAB9AHPGD
SCHEMBL5124639 0.80 PADI4 (0.51) PADI4PADI2ROCK2GRK2NPC1
SCHEMBL4174440 0.80 SHMT1 (0.41) NPC1RAB9AMCHR1HPGDHDAC1
SCHEMBL4168646 0.79 HDAC1 (0.48) PADI4PADI2NPC1RAB9AMCHR1
SCHEMBL4154125 0.76 PADI4 (0.41) PADI4PADI2NPC1RAB9AHPGD
SCHEMBL4165005 0.76 ALDH1A1 (0.41) PADI4PADI2NPC1RAB9AHDAC1
SCHEMBL4153988 0.75 L3MBTL1 (0.47) PADI4PADI2NAMPTSMN1; SMN2ALDH1A1
SCHEMBL4160443 0.75 KDM4E (0.39) NPC1RAB9AHPGDHDAC1HDAC2
SCHEMBL4166894 0.74 KDM4E (0.43) HPGDHDAC1HDAC2ALDH1A1SHMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed
EP-1945609-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2008-07-23 EP disclosed
WO-2007029036-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 PADI4 374/4885PADI2 495/4885ROCK2 2524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.